Matches in SemOpenAlex for { <https://semopenalex.org/work/W42203718> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W42203718 endingPage "9" @default.
- W42203718 startingPage "95" @default.
- W42203718 abstract "The use of cholecystokinin stimulation during cholescintigraphy to calculate the gallbladder ejection fraction has been associated with variable clinical results as a preoperative indicator for chronic acalculous cholecystitis and postoperative relief of biliary symptoms. A series of 56 consecutive patients was analyzed to determine the accuracy of a decreased gallbladder ejection fraction as a preoperative indicator for acalculous cholecystitis. Each patient had symptoms compatible with biliary disease. Each patient had a decreased gallbladder ejection fraction calculated by cholescintigraphy. The gallbladder ejection fraction was calculated using a 30-minute intravenous infusion of cholecystokinin at a dose of 0.02 microg/kg during cholescintigraphy. There was a 100% correlation found in this series of patients between a decreased gallbladder ejection fraction during cholescintigraphy, preoperative symptoms of gallbladder disease, and postoperative pathology evidence of acute or chronic cholecystitis. Only 1 patient had less than a complete resolution of her preoperative symptomatology after laparoscopic removal of her gallbladder. This patient had irritable bowel disease, which was diagnosed postoperatively. Six symptomatic patients with a gallbladder ejection fraction between 35% and 60% were also treated by laparoscopic removal of the gallbladder with complete resolution of their preoperative symptomatology. The use of a 30-minute infusion of cholecystokinin at a dose of 0.02 microg/kg to calculate the gallbladder ejection fraction during cholescintigraphy is an accurate test to preoperatively predict acalculous cholecystitis and postoperative relief of biliary symptoms. The gallbladder ejection fraction of less than 35% was abnormal. Cholecystectomy may be considered for patients whose gallbladder ejection fractions were calculated to be between 35% and 60% if the patient's symptoms were classical for biliary disease and have been present for 1 year. The use of a 30-minute intravenous infusion of cholecystokinin at a dose of 0.02 microg/kg to calculate the gallbladder ejection fraction during cholescintigraphy is an accurate test to preoperatively predict acalculous cholecystitis and postoperative relief of biliary symptoms." @default.
- W42203718 created "2016-06-24" @default.
- W42203718 creator A5032716788 @default.
- W42203718 date "2003-07-23" @default.
- W42203718 modified "2023-09-23" @default.
- W42203718 title "Gallbladder ejection fraction: an accurate evaluation of symptomatic acalculous gallbladder disease." @default.
- W42203718 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12872903" @default.
- W42203718 hasPublicationYear "2003" @default.
- W42203718 type Work @default.
- W42203718 sameAs 42203718 @default.
- W42203718 citedByCount "5" @default.
- W42203718 countsByYear W422037182012 @default.
- W42203718 countsByYear W422037182013 @default.
- W42203718 crossrefType "journal-article" @default.
- W42203718 hasAuthorship W42203718A5032716788 @default.
- W42203718 hasConcept C126322002 @default.
- W42203718 hasConcept C126838900 @default.
- W42203718 hasConcept C170493617 @default.
- W42203718 hasConcept C2775982439 @default.
- W42203718 hasConcept C2776493420 @default.
- W42203718 hasConcept C2776629433 @default.
- W42203718 hasConcept C2776641081 @default.
- W42203718 hasConcept C2777148285 @default.
- W42203718 hasConcept C2777593968 @default.
- W42203718 hasConcept C2778198053 @default.
- W42203718 hasConcept C2780354107 @default.
- W42203718 hasConcept C71924100 @default.
- W42203718 hasConcept C78085059 @default.
- W42203718 hasConcept C90924648 @default.
- W42203718 hasConceptScore W42203718C126322002 @default.
- W42203718 hasConceptScore W42203718C126838900 @default.
- W42203718 hasConceptScore W42203718C170493617 @default.
- W42203718 hasConceptScore W42203718C2775982439 @default.
- W42203718 hasConceptScore W42203718C2776493420 @default.
- W42203718 hasConceptScore W42203718C2776629433 @default.
- W42203718 hasConceptScore W42203718C2776641081 @default.
- W42203718 hasConceptScore W42203718C2777148285 @default.
- W42203718 hasConceptScore W42203718C2777593968 @default.
- W42203718 hasConceptScore W42203718C2778198053 @default.
- W42203718 hasConceptScore W42203718C2780354107 @default.
- W42203718 hasConceptScore W42203718C71924100 @default.
- W42203718 hasConceptScore W42203718C78085059 @default.
- W42203718 hasConceptScore W42203718C90924648 @default.
- W42203718 hasIssue "2" @default.
- W42203718 hasLocation W422037181 @default.
- W42203718 hasOpenAccess W42203718 @default.
- W42203718 hasPrimaryLocation W422037181 @default.
- W42203718 hasRelatedWork W1529854644 @default.
- W42203718 hasRelatedWork W1979710578 @default.
- W42203718 hasRelatedWork W1986682657 @default.
- W42203718 hasRelatedWork W2018217527 @default.
- W42203718 hasRelatedWork W2071957823 @default.
- W42203718 hasRelatedWork W2335140123 @default.
- W42203718 hasRelatedWork W2462983242 @default.
- W42203718 hasRelatedWork W2464264675 @default.
- W42203718 hasRelatedWork W42203718 @default.
- W42203718 hasRelatedWork W2741155310 @default.
- W42203718 hasVolume "88" @default.
- W42203718 isParatext "false" @default.
- W42203718 isRetracted "false" @default.
- W42203718 magId "42203718" @default.
- W42203718 workType "article" @default.